Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta‐analysis

Background  There have been conflicting data regarding the prevalence and clinicopathological characteristics of BRAF and NRAS mutations in primary cutaneous melanoma.

[1]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[2]  N. Hayward,et al.  The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population. , 2010, The Journal of investigative dermatology.

[3]  P. Ascierto,et al.  Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy , 2009, BMC Cancer.

[4]  R. Ádány,et al.  Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma , 2009, Modern Pathology.

[5]  S. Manoukian,et al.  Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT. , 2009, The Journal of investigative dermatology.

[6]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[7]  E. Grimm,et al.  Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma. , 2009, The Journal of investigative dermatology.

[8]  I. Wistuba,et al.  Allelotyping, Microsatellite Instability, and BRAF Mutation Analyses in Common and Atypical Melanocytic Nevi and Primary Cutaneous Melanomas , 2009, The American Journal of dermatopathology.

[9]  A. Emley,et al.  RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis , 2009, The British journal of dermatology.

[10]  J. Hansson,et al.  Lack of cytoplasmic ERK activation is an independent adverse prognostic factor in primary cutaneous melanoma. , 2008, The Journal of investigative dermatology.

[11]  Susan Muller,et al.  KIT Gene Mutations and Copy Number in Melanoma Subtypes , 2008, Clinical Cancer Research.

[12]  D. Elder,et al.  MC1R variants increase risk of melanomas harboring BRAF mutations. , 2008, The Journal of investigative dermatology.

[13]  Jane Fridlyand,et al.  Academic Editor: Jonathan Rees, University of Edinburgh, United Kingdom , 2007 .

[14]  C. Petti,et al.  In melanocytic lesions the fraction of BRAFV600E alleles is associated with sun exposure but unrelated to ERK phosphorylation , 2008, Modern Pathology.

[15]  J. Hansson,et al.  Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site , 2008, Molecular oncology.

[16]  S. Michiels,et al.  Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas , 2008, Molecular oncology.

[17]  R. Alani,et al.  BRAF kinase in melanoma development and progression , 2008, Expert Reviews in Molecular Medicine.

[18]  L. Akslen,et al.  Mutation analysis of the EGFR–NRAS–BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma , 2008, Melanoma research.

[19]  H. Tsao,et al.  Genetics of melanoma tumorigenesis , 2007, The British journal of dermatology.

[20]  Ju-Han Lee,et al.  Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid , 2007, Cancer.

[21]  T. Suzuki,et al.  Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion , 2007, The British journal of dermatology.

[22]  R. Millikan,et al.  Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[23]  M. Trivett,et al.  Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma. , 2007, The Journal of investigative dermatology.

[24]  J. Lundeberg,et al.  NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing , 2006, Melanoma research.

[25]  Stephen B Gruber,et al.  BRAF and NRAS mutations in melanoma and melanocytic nevi , 2006, Melanoma research.

[26]  G. Saldanha,et al.  Cutaneous Melanoma Subtypes Show Different BRAF and NRAS Mutation Frequencies , 2006, Clinical Cancer Research.

[27]  C. Massone,et al.  T1799A BRAF mutation is common in PUVA lentigines. , 2006, The Journal of investigative dermatology.

[28]  D. Krahl,et al.  The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites. , 2006, International journal of oncology.

[29]  C. Warneke,et al.  Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma. , 2006, The Journal of investigative dermatology.

[30]  J. Fridlyand,et al.  Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.

[31]  J. McCubrey,et al.  Analysis of BRAF Mutation in Primary and Metastatic Melanoma , 2005, Cell cycle.

[32]  R. MacKie,et al.  Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes. , 2005, The Journal of investigative dermatology.

[33]  S. Leung,et al.  BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs , 2005, Journal of Clinical Pathology.

[34]  F. Barany,et al.  Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction , 2005, Journal of cutaneous pathology.

[35]  W. Shih,et al.  Detection of B-RAF and N-RAS mutations in human melanoma. , 2005, Journal of the American College of Surgeons.

[36]  J. Davison,et al.  Absence of V599E BRAF mutations in desmoplastic melanomas , 2005, Cancer.

[37]  Kazuhiro Takahashi,et al.  BRAF point mutations in primary melanoma show different prevalences by subtype. , 2004, The Journal of investigative dermatology.

[38]  G. Reifenberger,et al.  Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas , 2004, International journal of cancer.

[39]  D. Morton,et al.  Incidence of BRAF Oncogene Mutation and Clinical Relevance for Primary Cutaneous Melanomas , 2004, Clinical Cancer Research.

[40]  F. Haluska,et al.  Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma. , 2004, The Journal of investigative dermatology.

[41]  K. Hemminki,et al.  Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9 , 2003, Oncogene.

[42]  M. Flaig,et al.  Mutations of the BRAF gene in benign and malignant melanocytic lesions. , 2003, The Journal of investigative dermatology.

[43]  Rui Qiao,et al.  BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma. , 2003, Cancer research.

[44]  Susan M. Kilroy,et al.  Malignant Transformation of Melanocytes to Melanoma by Constitutive Activation of Mitogen-activated Protein Kinase Kinase (MAPKK) Signaling* , 2003, The Journal of Biological Chemistry.

[45]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[46]  J. J. van den Oord,et al.  A novel N-ras mutation in malignant melanoma is associated with excellent prognosis. , 2001, Cancer research.

[47]  N. Hayward,et al.  Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. , 1996, The American journal of pathology.

[48]  H. Höfler,et al.  Ras gene mutations: a rare event in nonmetastatic primary malignant melanoma. , 1995, The Journal of investigative dermatology.

[49]  R. M. Mackie,et al.  Point mutations in the N‐ras oncogene in malignant melanoma and congenital naevi , 1994, The British journal of dermatology.

[50]  D. Spandidos,et al.  Ras gene-mutations are a rare event in human uveal and cutaneous melanomas. , 1994, Oncology reports.

[51]  J. Hoeffler,et al.  Ras mutations in human melanoma: a marker of malignant progression. , 1994, The Journal of investigative dermatology.

[52]  L. J. Veer,et al.  N-ras mutations in human cutaneous melanoma from sun-exposed body sites , 1989, Molecular and cellular biology.

[53]  F. McCormick,et al.  ras mutations in human melanotic lesions: K-ras activation is a frequent and early event in melanoma development. , 1989, Oncogene research.

[54]  C. Cordon-Cardo,et al.  Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. , 1989, Oncogene.